RM, N., Y, M., & Y, N. (2026). Dermal Interstitial Glycogenosis and Stromal Senescence-Associated Marker Expression in Fibrofolliculomas: Implications for Pathogenesis and mTOR-Targeted Therapy. The American Journal of dermatopathology, 48(8), 617-621. https://doi.org/10.1097/DAD.0000000000003336
Chicago Style (17th ed.) CitationRM, Nazarian, Miyagi Y, and Nakatani Y. "Dermal Interstitial Glycogenosis and Stromal Senescence-Associated Marker Expression in Fibrofolliculomas: Implications for Pathogenesis and MTOR-Targeted Therapy." The American Journal of Dermatopathology 48, no. 8 (2026): 617-621. https://doi.org/10.1097/DAD.0000000000003336.
MLA (9th ed.) CitationRM, Nazarian, et al. "Dermal Interstitial Glycogenosis and Stromal Senescence-Associated Marker Expression in Fibrofolliculomas: Implications for Pathogenesis and MTOR-Targeted Therapy." The American Journal of Dermatopathology, vol. 48, no. 8, 2026, pp. 617-621, https://doi.org/10.1097/DAD.0000000000003336.